BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32286519)

  • 21. Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse.
    Hassan SW; Doody KM; Hardy S; Uetani N; Cournoyer D; Tremblay ML
    PLoS One; 2010 Jan; 5(1):e8868. PubMed ID: 20111595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of TC-PTP (PTPN2) in modulating sensitivity to imatinib and interferon-α in CML cell line, KT-1 cells.
    Nishiyama-Fujita Y; Shimizu T; Sagawa M; Uchida H; Kizaki M
    Leuk Res; 2013 Sep; 37(9):1150-5. PubMed ID: 23759247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TC-PTP is required for the maintenance of MYC-driven B-cell lymphomas.
    Young RM; Polsky A; Refaeli Y
    Blood; 2009 Dec; 114(24):5016-23. PubMed ID: 19755676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
    Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
    Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of Grainy head-like 1 is associated with disruption of the epidermal barrier and squamous cell carcinoma of the skin.
    Mlacki M; Darido C; Jane SM; Wilanowski T
    PLoS One; 2014; 9(2):e89247. PubMed ID: 24586629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered expression of the epidermal growth factor receptor and transforming growth factor-alpha during multistage skin carcinogenesis in SENCAR mice.
    Rho O; Beltrán LM; Gimenez-Conti IB; DiGiovanni J
    Mol Carcinog; 1994 Sep; 11(1):19-28. PubMed ID: 7916986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion.
    Reddig PJ; Dreckschmidt NE; Zou J; Bourguignon SE; Oberley TD; Verma AK
    Cancer Res; 2000 Feb; 60(3):595-602. PubMed ID: 10676642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors.
    Matrisian LM; Bowden GT; Krieg P; Fürstenberger G; Briand JP; Leroy P; Breathnach R
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9413-7. PubMed ID: 3540938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAD2 overexpression in transgenic mice augments malignancy and tumor-associated inflammation in chemically initiated skin tumors.
    Mohanan S; Horibata S; Anguish LJ; Mukai C; Sams K; McElwee JL; McLean D; Yan A; Coonrod SA
    Cell Tissue Res; 2017 Nov; 370(2):275-283. PubMed ID: 28766045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of CD26 expression in epithelial cells and stromal cells during wound-induced skin tumour formation.
    Arwert EN; Mentink RA; Driskell RR; Hoste E; Goldie SJ; Quist S; Watt FM
    Oncogene; 2012 Feb; 31(8):992-1000. PubMed ID: 21765471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meis1 regulates epidermal stem cells and is required for skin tumorigenesis.
    Okumura K; Saito M; Isogai E; Aoto Y; Hachiya T; Sakakibara Y; Katsuragi Y; Hirose S; Kominami R; Goitsuka R; Nakamura T; Wakabayashi Y
    PLoS One; 2014; 9(7):e102111. PubMed ID: 25013928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression.
    Ostrowski LE; Finch J; Krieg P; Matrisian L; Patskan G; O'Connell JF; Phillips J; Slaga TJ; Breathnach R; Bowden GT
    Mol Carcinog; 1988; 1(1):13-9. PubMed ID: 3151258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein tyrosine phosphatome metabolic screen identifies TC-PTP as a positive regulator of cancer cell bioenergetics and mitochondrial dynamics.
    Vinette V; Aubry I; Insull H; Uetani N; Hardy S; Tremblay ML
    FASEB J; 2021 Jul; 35(7):e21708. PubMed ID: 34169549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages.
    Dhar SK; Tangpong J; Chaiswing L; Oberley TD; St Clair DK
    Cancer Res; 2011 Nov; 71(21):6684-95. PubMed ID: 22009531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
    Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR
    Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice.
    Arbeit JM; Riley RR; Huey B; Porter C; Kelloff G; Lubet R; Ward JM; Pinkel D
    Cancer Res; 1999 Aug; 59(15):3610-20. PubMed ID: 10446971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis.
    Yuspa SH; Kilkenny A; Cheng C; Roop D; Hennings H; Kruszewski F; Lee E; Strickland J; Greenhalgh DA
    Environ Health Perspect; 1991 Jun; 93():3-10. PubMed ID: 1773799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.
    Go C; Li P; Wang XJ
    Cancer Res; 1999 Jun; 59(12):2861-8. PubMed ID: 10383147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PKCepsilon overexpression, irrespective of genetic background, sensitizes skin to UVR-induced development of squamous-cell carcinomas.
    Sand JM; Aziz MH; Dreckschmidt NE; Havighurst TC; Kim K; Oberley TD; Verma AK
    J Invest Dermatol; 2010 Jan; 130(1):270-7. PubMed ID: 19626035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.